Who Paid My Doc
M14-222
ClinicalTrials.gov NCT02167945
Research payments
$961,300
Through program year 2020, $961,300 in research payments was reported against M14-222, across 359 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02167945
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $499,858 | 170 |
| 2019 | Research | $461,441 | 189 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Asma Siddique Seattle, WA Named on 15 payments
- Joseph Gathe Houston, TX Named on 14 payments
- Peter Varunok Poughkeepsie, NY Named on 13 payments
- Harvey Tatum Tulsa, OK Named on 13 payments
- Peter Ruane Los Angeles, CA Named on 12 payments
- Martin Moehlen New Orleans, LA Named on 12 payments
- Paul Kwo Stanford, CA Named on 11 payments
- Natarajan Ravendhran Catonsville, MD Named on 11 payments
- David Bernstein Manhasset, NY Named on 11 payments
- John Santoro Egg Harbor Township, NJ Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.